{"result": "(\"entity\"<|>EUROPEAN SOCIETY FOR CLINICAL NUTRITION AND METABOLISM<|>ORGANIZATION<|>The European Society for Clinical Nutrition and Metabolism (ESPEN) published guidelines for nutritional support in neurological pathologies in 2017, reflecting the specialization in clinical nutrition based on current literature.)\n##\n(\"entity\"<|>ENFERMEDAD DE PARKINSON<|>EVENT<|>Parkinson's disease is a neurological condition with a high prevalence of swallowing disorders (oropharyngeal dysphagia) and associated risks of malnutrition.)\n##\n(\"entity\"<|>ICTUS<|>EVENT<|>Stroke is a neurological condition that can lead to oropharyngeal dysphagia and malnutrition.)\n##\n(\"entity\"<|>ESCLEROSIS MÚLTIPLE<|>EVENT<|>Multiple sclerosis is a neurological condition that poses a high risk for oropharyngeal dysphagia and malnutrition.)\n##\n(\"entity\"<|>ESCLEROSIS LATERAL AMIOTRÓFICA<|>EVENT<|>Amyotrophic lateral sclerosis is a neurological condition associated with a high risk of oropharyngeal dysphagia and malnutrition.)\n##\n(\"entity\"<|>SWALLOWING DISTURBANCE QUESTIONNAIRE<|>ORGANIZATION<|>The Swallowing Disturbance Questionnaire (SDQ) is a tool recommended for screening swallowing disorders in patients with Parkinson's disease.)\n##\n(\"entity\"<|>DYSphAGIA TEST-PARKINSON'S DISEASE<|>ORGANIZATION<|>The Dysphagia Test-Parkinson's Disease (MDT-PD) is a tool recommended for screening swallowing disorders in patients with Parkinson's disease.)\n##\n(\"entity\"<|>FIBEROPTIC ENDOSCOPIC EVALUATION OF SWALLOWING<|>ORGANIZATION<|>Fiberoptic Endoscopic Evaluation of Swallowing (FEES) is an instrumental assessment recommended for evaluating swallowing disorders.)\n##\n(\"entity\"<|>VIDEOFLOUROSCOPIA<|>ORGANIZATION<|>Videofluoroscopy (VFFS) is an instrumental assessment recommended for evaluating swallowing disorders when FEES is not possible.)\n##\n(\"entity\"<|>LEVODOPA<|>ORGANIZATION<|>Levodopa is a medication used in the treatment of Parkinson's disease, which requires careful dietary management for optimal absorption.)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY FOR CLINICAL NUTRITION AND METABOLISM<|>ENFERMEDAD DE PARKINSON<|>ESPEN published guidelines addressing nutritional support for patients with Parkinson's disease<|>7)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY FOR CLINICAL NUTRITION AND METABOLISM<|>ICTUS<|>ESPEN published guidelines addressing nutritional support for patients who have suffered a stroke<|>7)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY FOR CLINICAL NUTRITION AND METABOLISM<|>ESCLEROSIS MÚLTIPLE<|>ESPEN published guidelines addressing nutritional support for patients with multiple sclerosis<|>7)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY FOR CLINICAL NUTRITION AND METABOLISM<|>ESCLEROSIS LATERAL AMIOTRÓFICA<|>ESPEN published guidelines addressing nutritional support for patients with amyotrophic lateral sclerosis<|>7)\n##\n(\"relationship\"<|>ENFERMEDAD DE PARKINSON<|>SWALLOWING DISTURBANCE QUESTIONNAIRE<|>The SDQ is recommended for screening swallowing disorders in patients with Parkinson's disease<|>8)\n##\n(\"relationship\"<|>ENFERMEDAD DE PARKINSON<|>DYSphAGIA TEST-PARKINSON'S DISEASE<|>The MDT-PD is recommended for screening swallowing disorders in patients with Parkinson's disease<|>8)\n##\n(\"relationship\"<|>ENFERMEDAD DE PARKINSON<|>FIBEROPTIC ENDOSCOPIC EVALUATION OF SWALLOWING<|>FEES is recommended for instrumental assessment of swallowing disorders in Parkinson's patients<|>8)\n##\n(\"relationship\"<|>ENFERMEDAD DE PARKINSON<|>VIDEOFLOUROSCOPIA<|>VFFS is recommended for instrumental assessment of swallowing disorders when FEES is not possible in Parkinson's patients<|>8)\n##\n(\"relationship\"<|>LEVODOPA<|>ENFERMEDAD DE PARKINSON<|>Levodopa is a primary treatment for Parkinson's disease, requiring dietary management for effective absorption<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Baja sensibilidad. No se requiere cooperación por parte del paciente | Cuestionario más test del agua | Baja especificidad | Baja sensibilidad y especificidad | Buena sensibilidad | Saliva+deglución de texturas | Incluye WST |\n\n## 4. ESPEN GUIDELINES 2017: REVISIÓN\n\nLa Europiean Society for Clinical Nutrition and Metabolism (ESPEN) ha publicado\nlas guías de soporte nutricional en patologías neurológicas 2017¹⁴, donde queda re-\nflejado el nivel de especialización que tiene la nutrición clínica basada en la literatura\nactual.\n\nLa guía ha sido elaborada por un equipo multidisciplinar compuesto por espe-\ncialistas en cuidados intensivos, neurólogos, geriatras, nutrición clínica, dietética y\nrehabilitación.\n\n40\n---\n## 2. Métodos de cribado para la disfagia orofaríngea\n\nEsta guía se centra en cuatro patologías: esclerosis múltiple, enfermedad de Parkinson, ictus y esclerosis lateral amiotrófica. Todas estas patologías tienen un alto riesgo de cursar con trastornos de la deglución (disfagia orofaríngea) y alto riesgo de desnutrición.\n\nSe aplicó el sistema de preguntas PICO y revisión bibliográfica, donde se obtuvieron 88 recomendaciones, el 91,8% tras votaciones obtuvo strong consensus. Para la clasificación del nivel de evidencia de las recomendaciones (GR) se utilizó el sistema de graduación de la Scottish Intercollegiate Guideline Network. En esta guía se recogen 4 recomendaciones grado A, 31 grado B, 9 grado C y 44 recomendaciones por grupo de expertos (GPP).\n\nLas conclusiones en relación con la valoración y tratamiento de la disfagia en las distintas enfermedades neurológicas valoradas fueron:\n\n- **Enfermedad de Parkinson.** Debido a la alta prevalencia de disfagia en pacientes con enfermedad de Parkinson en estadio II de Hoehn & Yahr o pérdida de peso, bajo índice de masa corporal, babeo, demencia o signos de disfagia se debe realizar cribado de esta con el paciente en fase ON (grado de recomendación B con un consenso del 95%).\n\n  - **Cribado de la DOF.** Las herramientas que recomiendan son Swallowing disturbance questionnaire (SDQ) y Dysphagia test-Parkinson's disease (MDT-PD) (grado recomendación B con un consenso del 91%). Se recomienda que, una vez detectada la DOF mediante el screening, se realice una valoración instrumental, como primera opción, realización de Fiberoptic Endoscopic Evaluation of Swallowing (FEES) y si esta no fuese posible, videofluoroscopia (VFFS) en todos los pacientes. Estas medidas también se tomarán en todos los pacientes que presenten un rápido deterioro de la enfermedad, neumonías u otros signos sospechosos de disfagia (grado de recomendación GPP con un consenso del 100%).\n\n  - **Tratamiento de la DOF.** Para mejorar los síntomas que contribuyen a la DOF es prioritario optimizar el tratamiento para la enfermedad de Parkinson (grado de recomendación B con un consenso del 100%). En cuanto a la rehabilitación, a pesar de no existir estudios randomizados ni controlados, se deben recomendar, de forma individual y después de un asesoramiento de la función deglutoria, programas de rehabilitación de la DOF como maniobras posturales, adaptación del bolo, etc. No se pueden recomendar de forma generalizada, por no haberse podido contrastar adecuadamente, otras técnicas como la estimulación de superficie, la estimulación repetitiva transcraneal magnética o terapia de deglución videoasistida (grado de\n---\n# MANUAL DE DISFAGIA OROFARÍNGEA: SOLUCIONES MULTIDISCIPLINARES\n\nrecomendación GPP con un consenso del 100%). Paralelamente, las guías establecen la necesidad de monitorizar el peso de los pacientes en el curso de la enfermedad, así como el estatus vitamínico valorando los cambios de peso y la necesidad de suplementar vitamina D, ácido fólico y vitamina B12 (grado de recomendación B con un consenso del 91%). Así mismo, se recomienda poner especial atención en vigilar el estatus de los niveles de homocisteína y vitaminas del grupo B, por su interrelación con el tratamiento con la levodopa (grado de recomendación GPP con un consenso del 95%). Igualmente, con un grado B de recomendación se establece la conveniencia de advertir de la necesidad de ajuste proteico y los tiempos de las ingestas durante la toma de levodopa para optimizar su absorción y eficacia. Se recomienda también aumentar el consumo de pre- y probióticos, mejorando así la hidratación para tratar el estreñimiento\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}